Having rich experience and thorough understanding of the market operations, we are engaged in manufacturing and exporting Epirubicin Hydrochloride Injection. The drug is useful for breast cancer, gastric cancer and lung cancer. Highly demanded in the market, these drugs are formulated in compliance with the safety measures of the industry using only finest quality compounds. We make the Epirubicin Hydrochloride Injection available for the clients in different quantity packaging options.
No side effects
Long shelf life
Epirubicin Hydrochloride Injection
- Breast Cancer
- Ovarian Cancer
- Gastric Cancer
- Lung Cancer
Epirubicin is given in repeated 3 to 4 week cycles.
The total dose of Epirubicin may be given on Day 1 of each cycle or divided equally and given on Days 1 and 8 of each cycle. The recommended dosages of Epirubicin are as follows :
Starting Doses : The recommended starting dose of Epirubicin is 100 to 120 mg/m2. The following regimens were used in the trials supporting use of Epirubicin as a component of adjuvant therapy in patients with axillary-node positive breast cancer;
CEF-120 : Cyclophosphamide-75 mg/m2 PO Day 1-14 Epirubicin- 60 mg/m2 IV Day 1, 8 5-Fluorouracil -500 mg/m2 IV Day 1, 8 Repeated every 28 days for 6 cycles
FEC-100 : 5-Fluorouracil- 500 mg/m2, Epirubicin- 100 mg/m2, Cyclophosphamide- 500 mg/m2
Dosage Adjustment :
Renal Impairment : Administer with caution.
Hepatic Impairment : Required.
Packing: 5 Vials of 10 mg
We also deals in:
|Name of the Product||Composition|
|Epirubitec 10mg Injection||Epirubicin Hydrochloride 10mg|
|Epirubitec 50mg Injection||Epirubicin Hydrochloride 50mg|
FC/B-1 (Extn.), Mohan Co-operative Industrial Estate, Mathura Road, New Delhi, Delhi, 110044, India